Search Results 951-960 of 1584 for 贵阳用友软件 www.w-t.cn
The primary objective of this study is to describe the safety and toxicity of grid + immunotherapy in stage IV NSCLC using CTCAE v5.0. Participation eligibility.
Danilov AV, Sauter C, Phillips T, Coombs CC, Ip A, Wang Y, Rhodes J, Leslie L, Barrientos J, Saeed H, Strati P, Barta SK, Shadman M. Perspectives on Current ...
About this study. The primary objectives of this study are to obtain serological bone turnover markers and bone mineral density (BMD) measurements from ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL).
The puropose of this study is to utilize a discrete-choice experiment (DCE) survey to elicit benefit-risk preferences for interventional treatment attributes in ...
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO. Participation ...
In this research study, the investigators are testing a new type of breast camera, called Molecular Breast Imaging, to see if it can find tumors in the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.